Abstract:Chronic rhinosinusitis (CRS) is a multifactorial infection of the nasal cavity and sinuses. In this study, nasal swabs from control donors (N = 128) and patients with CRS (N = 246) were analysed. Culture methods and metagenomics revealed no obvious differences in the composition of the bacterial communities between the two groups. However, at the functional level, several metabolic pathways were significantly enriched in the CRS group compared to the control group. Pathways such as carbohydrate transport metabolism, ATP synthesis, cofactors and vitamins, photosynthesis and transcription were highly enriched in CRS. In contrast, pathways related to lipid metabolism were more representative in the control microbiome. As S. aureus is one of the main species found in the nasal cavity, staphylococcal isolates from control and CRS samples were analysed by microarray and functional assays. Although no significant genetic differences were detected by microarray, S. aureus from CRS induced less cytotoxicity to lung cells and lower rates of glycolysis in host cells than control isolates. These results suggest the differential modulation of staphylococcal virulence by the environment created by other microorganisms and their interactions with host cells in control and CRS samples. These changes were reflected in the differential expression of cytokines and in the expression of Agr, the most important quorum-sensing regulator of virulence in S. aureus. In addition, the CRS isolates remained stable in their cytotoxicity, whereas the cytotoxic activity of S. aureus isolated from control subjects decreased over time during in vitro passage. These results suggest that host factors influence the virulence of S. aureus and promote its adaptation to the nasal environment during CRS.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore whether there are differences in cytotoxicity and glycolysis between *Staphylococcus aureus* isolated from the nasal cavities of patients with chronic rhinosinusitis (CRS) compared with the healthy control group, and whether these differences reflect the adaptation strategies of the bacteria to the host environment. Specifically, researchers explored the following points by analyzing nasal swab samples from CRS patients and the healthy control group, using culture methods and metagenomics techniques: 1. **Microbial community composition**: Compare the differences in nasal microbial community composition between CRS patients and the healthy control group. 2. **Differences in metabolic pathways**: At the functional level, explore the significant differences in metabolic pathways between CRS patients and the healthy control group. 3. **Genetic characteristics of *Staphylococcus aureus***: Detect the genetic differences of *Staphylococcus aureus* in CRS patients and the healthy control group through microarray analysis. 4. **Cytotoxicity and glycolytic activity**: Evaluate the effects of *Staphylococcus aureus* on the cytotoxicity and glycolytic activity of lung cells in CRS patients and the healthy control group through functional experiments. 5. **Changes in cytotoxicity after long - term passage**: Study the changes in the cytotoxicity of *Staphylococcus aureus* in CRS patients and the healthy control group after continuous passage in vitro. Through these analyses, researchers hope to reveal whether *Staphylococcus aureus* in the nasal cavities of CRS patients adapts to the host environment by reducing cytotoxicity and glycolytic activity, thereby affecting its survival and pathogenic ability in chronic infections.

Reduced Glycolysis and Cytotoxicity in Staphylococcus aureus Isolates from Chronic Rhinosinusitis as Strategies for Host Adaptation